Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 3.00 is 11% above its 5-year average of 2.71, around the middle of its 5-year range (2.05–3.67).
As of the fiscal period ended Tuesday, June 30, 2026. 5.07% below its 12-month average of 3.16.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.00.
QUICK RATIO (ACID-TEST)
3.00
QUICK RATIO (ACID-TEST) AVG TTM
3.16
QUICK RATIO (ACID-TEST) AVG 3Y
2.91
QUICK RATIO (ACID-TEST) AVG 5Y
2.71
QUICK RATIO (ACID-TEST) AVG 10Y
2.07
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-5.07%
CURRENT VS 3Y AVG
+3.06%
CURRENT VS 5Y AVG
+10.66%
CURRENT VS 10Y AVG
+45.13%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
-10.38%
vs the sector median at left
Organogenesis Holdings Inc.
Market Cap
$169.21M
Quick Ratio (Acid-Test)
3.00
TTM Avg
3.16
3Y Avg
2.91
5Y Avg
2.71
Market Cap
$170.32M
Quick Ratio (Acid-Test)
12.82
TTM Avg
9.83
3Y Avg
6.43
5Y Avg
5.45
Market Cap
$169.18M
Quick Ratio (Acid-Test)
2.09
TTM Avg
2.02
3Y Avg
3.00
5Y Avg
2.71
Market Cap
$171.00M
Quick Ratio (Acid-Test)
1.25
TTM Avg
2.29
3Y Avg
3.57
5Y Avg
4.16
Market Cap
$167.06M
Quick Ratio (Acid-Test)
7.98
TTM Avg
13.57
3Y Avg
13.59
5Y Avg
18.24
Market Cap
$166.45M
Quick Ratio (Acid-Test)
5.58
TTM Avg
2.96
3Y Avg
5.18
5Y Avg
6.05
Market Cap
$173.31M
Quick Ratio (Acid-Test)
1.41
TTM Avg
1.25
3Y Avg
1.14
5Y Avg
1.20
Market Cap
$164.64M
Quick Ratio (Acid-Test)
2.45
TTM Avg
5.00
3Y Avg
7.69
5Y Avg
7.91
Market Cap
$174.29M
Quick Ratio (Acid-Test)
3.49
TTM Avg
3.52
3Y Avg
4.49
5Y Avg
5.44
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Organogenesis Holdings Inc. (ORGO) | $169.21M | 3.00 | 3.16 | 2.91 | 2.71 |
| Precision BioSciences, Inc. (DTIL)vs › | $170.32M | 12.82 | 9.83 | 6.43 | 5.45 |
| MediWound Ltd. (MDWD)vs › | $169.18M | 2.09 | 2.02 | 3.00 | 2.71 |
| Cue Biopharma, Inc. (CUE)vs › | $171.00M | 1.25 | 2.29 | 3.57 | 4.16 |
| Nkarta, Inc. (NKTX)vs › | $167.06M | 7.98 | 13.57 | 13.59 | 18.24 |
| OptimizeRx Corp. (OPRX)vs › | $166.45M | 5.58 | 2.96 | 5.18 | 6.05 |
| Journey Medical Corporation (DERM)vs › | $173.31M | 1.41 | 1.25 | 1.14 | 1.20 |
| Quanterix Corporation (QTRX)vs › | $164.64M | 2.45 | 5.00 | 7.69 | 7.91 |
| ProQR Therapeutics N.V. (PRQR)vs › | $174.29M | 3.49 | 3.52 | 4.49 | 5.44 |
| Compass Therapeutics, Inc. (CMPX)vs › | $177.73M | 11.22 | 14.99 | 15.44 | 13.43 |
Quick Ratio
3.00
Excludes inventory
Current Ratio
3.52
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 3.00 |
| 2026-03-31 | 3.16 |
| 2025-12-31 | 3.32 |
| 2025-09-30 | 2.88 |
| 2025-06-30 | 3.45 |
| 2025-03-31 | 3.67 |
| 2024-12-31 | 3.35 |
| 2024-09-30 | 2.74 |
| 2024-06-30 | 2.42 |
| 2024-03-31 | 2.41 |
| 2023-12-31 | 2.44 |
| 2023-09-30 | 2.43 |
| 2023-06-30 | 2.60 |
| 2023-03-31 | 2.51 |
| 2022-12-31 | 2.64 |
| 2022-09-30 | 2.31 |
| 2022-06-30 | 2.36 |
| 2022-03-31 | 2.54 |
| 2021-12-31 | 2.44 |
| 2021-09-30 | 2.25 |
| 2021-06-30 | 2.05 |
| 2021-03-31 | 2.10 |
| 2020-12-31 | 2.15 |
| 2020-09-30 | 1.50 |
| 2020-06-30 | 1.35 |
| 2020-03-31 | 1.55 |
| 2019-12-31 | 1.71 |
| 2019-09-30 | 1.07 |
| 2019-06-30 | 1.14 |
| 2019-03-31 | 1.28 |
| 2018-12-31 | 0.87 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.03 |
| 2018-03-31 | 0.12 |
| 2017-12-31 | 0.07 |
| 2017-09-30 | 0.04 |
| 2017-06-30 | 3.34 |
| 2017-03-31 | 3.45 |
| 2016-12-31 | 3.00 |
| 2016-09-30 | 2.88 |
| 2016-06-30 | 0.17 |
| 2016-03-31 | 0.00 |
